Identification of patients with developing ulcerative colitis-associated neoplasia by nitrative dna damage marker 8-nitroguanin expression in rectal mucosa

Journal of Clinical Gastroenterology

Volumn 47, Issue 9, 2013, Pages e80-e86

  Saigusa, Susumu ^a   Araki, Toshimitsu ^a   Tanaka, Koji ^a   Hashimoto, Kiyoshi ^a   Okita, Yoshiki ^a   Fujikawa, Hiroyuki ^a   Okugawa, Yoshinaga ^a   Toiyama, Yuji ^a   Inoue, Yasuhiro ^a   Uchida, Keiichi ^a   Mohri, Yasuhiko ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

8 NG; Field effect; Surveillance; Ulcerative colitis associated neoplasia

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 NITROGUANINE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHILD; COLITIS; COLON CANCER; COLON MUCOSA; COLORECTAL CANCER; CRYPT CELL; DISEASE DURATION; DISEASE SEVERITY; DNA DAMAGE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; NITRATIVE STRESS; OXIDATIVE STRESS; PANCOLITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCTITIS; PROCTOCOLECTOMY; RECTUM MUCOSA; SCHOOL CHILD; ULCERATIVE COLITIS; ULCERATIVE COLITIS ASSOCIATED CANCER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DNA DAMAGE; FEMALE; GUANINE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LOGISTIC MODELS; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84884669480     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31828f51e1     Document Type: Article

References (45)

1. Coussens LM, Werb Z.Inflammation and cancer.Nature.2002;420:860-867.
2. Danese S, Fiocchi C.Ulcerative colitis.N Engl J Med.2011;365:1713-1725.
3. Eaden JA, Abrams KR, Mayberry JF.The risk of colorectal cancer in ulcerative colitis: a meta-analysis.Gut.2001;48:526-535.
4. Cho JH, Brant SR.Recent insights into the genetics of inflammatory bowel disease.Gastroenterology.2011;140:1704-1712.
5. Thompson AI, Lees CW.Genetics of ulcerative colitis.Inflamm Bowel Dis.2011;17:831-848.
6. Hussain SP, Hofseth LJ, Harris CC.Radical causes of cancer.Nat Rev Cancer.2003;3:276-285.
7. Murata M, Thanan R, Ma N, et al.Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis.J Biomed Biotechnol.2012;2012:623019.
8. Kawanishi S, Hiraku Y.Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation.Antioxid Redox Signal.2006;8:1047-1058.
9. Hiraku Y.Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance.Environ Health Prev Med.2009;15:63-72.
10. Inoue S, Kawanishi S.Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide.FEBS Lett.1995;371:86-88.
11. Bruner SD, Norman DP, Verdine GL.Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA.Nature.2000;403:859-866.
12. Shibutani S, Takeshita M, Grollman AP.Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG.Nature.1991;349:431-434.
13. Ullman T, Odze R, Farraye FA.Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon.Inflamm Bowel Dis.2009;15:630-638.
14. Itzkowitz SH, Present DH.Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease.Inflamm Bowel Dis.2005;11:314-321.
15. Velayos FS, Liu L, Lewis JD, et al.Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system.Gastroenterology.2010;139:1511-1518.
16. Chai H, Brown RE.Field effect in cancer-an update.Ann Clin Lab Sci.2009;39:331-337.
17. Slaughter DP, Southwick HW, Smejkal W.Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.Cancer.1953;6:963-968.
18. Watanabe T, Kobunai T, Yamamoto Y, et al.Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis.Clin Colorectal Cancer.2011;10:134-141.
19. Hsieh CJ, Klump B, Holzmann K, et al.Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.Cancer Res.1998;58:3942-3945.
20. Brentnall TA, Crispin DA, Bronner MP, et al.Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.Cancer Res.1996;56:1237-1240.
21. Watanabe T, Kobunai T, Toda E, et al.Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray.Clin Cancer Res.2007;13:415-420.
22. Risques RA, Lai LA, Himmetoglu C, et al.Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.Cancer Res.2011;71:1669-1679.
23. Salk JJ, Salipante SJ, Risques RA, et al.Clonal expansions in ulcerative colitis identify patients with neoplasia.Proc Natl Acad Sci USA.2009;106:20871-20876.
24. Wong SC, Lo SF, Lee KC, et al.Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.J Pathol.2002;196:145-153.
25. Eaden JA, Mayberry JF.Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.Gut.2002;51suppl 5V10-V12.
26. Rutter MD, Saunders BP, Wilkinson KH, et al.Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.Gastroenterology.2006;130:1030-1038.
27. Kornbluth A, Sachar DB.Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol.2010;105:501-523quiz 524.
28. Collins PD, Mpofu C, Watson AJ, et al.Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev.2006;19:CD000279.
29. Hata K, Watanabe T, Kazama S, et al.Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.Br J Cancer.2003;89:1232-1236.
30. Rex DK.Preventing colorectal cancer and cancer mortality with colonoscopy: what we know and what we don’t know.Endoscopy.2010;42:320-323.
31. Chen R, Rabinovitch PS, Crispin DA, et al.DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.Am J Pathol.2003;162:665-672.
32. Neumann H, Vieth M, Langner C, et al.Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.World J Gastroenterol.2011;17:3184-3191.
33. Matsumoto T, Kudo T, Jo Y, et al.Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study.Gastrointest Endosc.2007;66:957-965.
34. Neumann H, Kiesslich R, Wallace MB, et al.Confocal laser endomicroscopy: technical advances and clinical applications.Gastroenterology.2010;139:392.e1-392.e2.
35. Bista RK, Brentnall TA, Bronner MP, et al.Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia.Inflamm Bowel Dis.2011;17:2427-2435.
36. Kiesslich R.Chromoendoscopy: what is its true value for ulcerative colitis surveillance?Dig Dis.2010;28:445-451.
37. Watanabe T, Ajioka Y, Matsumoto T, et al.Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial.J Gastroenterol.2011;46suppl 111-16.
38. Hussain SP, Amstad P, Raja K, et al.Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.Cancer Res.2000;60:3333-3337.
39. Yoshida T, Mikami T, Mitomi H, et al.Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.J Pathol.2003;199:166-175.
40. Okayasu I.Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.Pathol Int.2012;62:368-380.
41. Cho KR, Vogelstein B.Genetic alterations in the adenoma—carcinoma sequence.Cancer.1992;70:1727-1731.
42. Leslie A, Carey FA, Pratt NR, et al.The colorectal adenoma-carcinoma sequence.Br J Surg.2002;89:845-860.
43. Weitz J, Koch M, Debus J, et al.Colorectal cancer.Lancet.2005;365:153-165.
44. Tarmin L, Yin J, Harpaz N, et al.Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.Cancer Res.1995;55:2035-2038.
45. Brentnall TA, Crispin DA, Rabinovitch PS, et al.Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.Gastroenterology.1994;107:369-378.